Skip to main content
. 2024 Nov 5;14:26793. doi: 10.1038/s41598-024-77331-8

Fig. 2.

Fig. 2

Dot Blot Assay. 1: Preparation buffer as the negative control, 2: API batch (400CR531) of Soberana Plus, 3 & 4: API batches of PastoCovac Plus, 5: RBD dimer as the positive control. The immunoassay result shows that the dots belonging to two different batches of the produced API (CR-API-40002 and CR-API-40003) are in a similar strength range of the positive control.